Obesity Clinical Trials

Showing 341-360 of 4,967 trials

A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin.

NCT07121153

The study is testing a new medicine (NNC0487-0111) for weight control in Chinese people with BMI between 24 kilogram per meter square (kg/m2) and 34.9 kg/m2. The aim of the study is to see how safe the study medicine is and how it behaves in human body. Participants will either get the study medicine or placebo (a "dummy medicine" similar to the study medicine but without active ingredients) and which treatment they get is decided by chance. The study medicine is a potential new medicine which cannot be prescribed by doctors but has previously been tested in humans. This study will last for up to 53 days.

OverweightObesity

Novo Nordisk A/S36 participantsStarted Aug 2025

Jinan, Shandong, China

Active Not RecruitingNA

Responsive Neurostimulation For Loss Of Control Eating

NCT03868670

The primary objective of this trial is to assess device function and safety, with secondary objectives including the feasibility.

Loss of Control EatingObesity, Morbid

University of Pennsylvania6 participantsStarted Apr 2019

Stanford, California, United States • Philadelphia, Pennsylvania, United States

RECRUITING

Characterization and Phenotyping of Patients Who Are Offered Drug Therapy for Obesity

NCT07414043

The study is multicenter and observational, consisting of a cross-sectional phase (V0) in which data will be collected from patients who are offered drug therapy, and a prospective longitudinal phase in which only patients who agree to start drug therapy for obesity will be involved

Obesity & Overweight

IRCCS Azienda Ospedaliero-Universitaria di Bologna500 participantsStarted Oct 2025

Bologna, Bologna, Italy

A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin.

Responsive Neurostimulation For Loss Of Control Eating

Characterization and Phenotyping of Patients Who Are Offered Drug Therapy for Obesity

Related Searches

CARBON: UAB Cardiovascular Research Biobank

Effects of Exercise on Lipids and Endothelial Function in Youth

OverStitch NXT Endoscopic Suture System

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

Incretin-based Therapies, Nutrition, and Physical Activity

Respiratory Muscle Training to Improve Cerebrovascular and Immune Function

Prophylactic Use of APRV Before Extubation in Morbidly Obese Patients After Cardiac Surgery.

Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression

A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti

Examining the Role of Executive Functioning in Family-Based Intensive Health Behavior and Lifestyle Treatment

The Integrated Population (I-POP) Health Trial

A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity

Biobehavioral Reward Responses Associated With Consumption of Nutritionally Diverse Ultra-Processed Foods

The BEE-Power Study (Boosting Exercise for Excellent Pediatric Blood Pressure)

Bariatric Surgery Versus Diet Alone in the Bile Acid Pathway and Weight Loss

SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial

Family Functioning in Obesity Treatment for Mexican Americans